TY - JOUR
T1 - Latin American consensus on tapering of biological therapy in psoriasis
AU - Londoño-García, Angela María
AU - Castro-Ayarza, Juan Raúl
AU - Franco Franco, Manuel Darío
AU - González Ardila, Cesar Fernando
AU - Magariños, Gabriel
AU - Rivas Zaldívar, Enrique Salvador
AU - Martínez, Susan
AU - Ibatá, Linda
AU - Castillo, Julieth Carolina
AU - Cárdenas Rojas, Paola Jimena
AU - Castro Vargas, Evelyn Giuliana
AU - Contreras, Claudia Romina
AU - de la Cruz Fernández, Claudia
AU - Chavarriaga Restrepo, Andrés
AU - Echeverria, Cristina Mariela
AU - Esteves de Carvalho, André Vicente
AU - Hidalgo Matlock, Benjamín
AU - Loayza, Enrique
AU - Maskin, Matías Rafael
AU - Romiti, Ricardo
AU - Valenzuela, Fernando
N1 - Publisher Copyright:
© 2025 Sociedade Brasileira de Dermatologia
PY - 2025/7/1
Y1 - 2025/7/1
N2 - Background: Biologic therapy is an effective psoriasis treatment. However, its long-term use carries the risk of serious adverse effects and high costs for the healthcare system, which is particularly relevant in resource-limited Latin American countries. Therefore, there is scientific interest in exploring the feasibility of tapering therapy in low disease activity or clinical remission. Objective: To provide expert consensus-based recommendations to guide personalized and efficient tapering of biologic agents in adult patients with cutaneous psoriasis. Methods: Following an exhaustive systematic literature review, a consensus was developed using a modified Delphi methodology by a group of Latin American clinical dermatologists and an independent methodological team. The topics covered include treatment goals, tapering objectives and strategies, regimens, monitoring and tapering failure, and implementation considerations in patients with psoriasis treated with biological agents. Results: The expert panel reached a consensus on five general principles and 13 recommendations for tapering biological therapy for psoriasis. These recommendations provide scientific support for dermatologists and healthcare providers regarding criteria for tapering, strategies and regimens, monitoring, failure management, and considerations for implementation. Conclusion: Tapering of biologics appears to be effective and safe in psoriasis patients with low stable activity or clinical remission. This Latin American consensus was developed in recognition of the need for rational and optimal use of biologics, while individualizing cases to apply best clinical practices.
AB - Background: Biologic therapy is an effective psoriasis treatment. However, its long-term use carries the risk of serious adverse effects and high costs for the healthcare system, which is particularly relevant in resource-limited Latin American countries. Therefore, there is scientific interest in exploring the feasibility of tapering therapy in low disease activity or clinical remission. Objective: To provide expert consensus-based recommendations to guide personalized and efficient tapering of biologic agents in adult patients with cutaneous psoriasis. Methods: Following an exhaustive systematic literature review, a consensus was developed using a modified Delphi methodology by a group of Latin American clinical dermatologists and an independent methodological team. The topics covered include treatment goals, tapering objectives and strategies, regimens, monitoring and tapering failure, and implementation considerations in patients with psoriasis treated with biological agents. Results: The expert panel reached a consensus on five general principles and 13 recommendations for tapering biological therapy for psoriasis. These recommendations provide scientific support for dermatologists and healthcare providers regarding criteria for tapering, strategies and regimens, monitoring, failure management, and considerations for implementation. Conclusion: Tapering of biologics appears to be effective and safe in psoriasis patients with low stable activity or clinical remission. This Latin American consensus was developed in recognition of the need for rational and optimal use of biologics, while individualizing cases to apply best clinical practices.
KW - Biological therapy
KW - Consensus
KW - Delphi technique
KW - Drug tapering
KW - Latin America
KW - Psoriasis
UR - https://www.scopus.com/pages/publications/105008245809
U2 - 10.1016/j.abd.2025.501134
DO - 10.1016/j.abd.2025.501134
M3 - Article
C2 - 40554355
AN - SCOPUS:105008245809
SN - 0365-0596
VL - 100
JO - Anais Brasileiros de Dermatologia
JF - Anais Brasileiros de Dermatologia
IS - 4
M1 - 501134
ER -